ELOCON ® Mometasone

ELOCON ® is a drug based on Mometasone furoate

THERAPEUTIC GROUP: Non-associated corticosteroids, dermatological preparations

IndicationsAction mechanismStudies and clinical effectiveness Usage and dosage instructionsWarnings Pregnancy and lactationInteractionsContraindicationsUndesirable effects

Indications ELOCON ® Mometasone

ELOCON ® is indicated in the treatment of dermatitis, neurodermatitis, psoriasis, eczema, sunburn and all other forms of inflammatory skin diseases sensitive to treatment with corticosteroids.

Mechanism of action ELOCON ® Mometasone

The Mometasone, active ingredient of ELOCON ®, is a recently introduced synthetic corticosteroid, endowed with particular pharmacokinetic properties that allow the setting of therapeutic plans based on daily single administration.

Against these pharmacokinetic properties, the pharmacodynamic properties are the same as those of other corticosteroids, therefore characterized by the ability to induce the expression of proteins such as Lipocortin capable of inhibiting the enzyme Phospholipase A2, initiator of the molecular events leading to the production of prostaglandins, chemical mediators endowed with marked pro-inflammatory activities, platelet aggregating and edemigene.

All this takes the form of a prompt remission of the complained symptomatology and a clear improvement in the quality of life of the affected patient.

Studies carried out and clinical efficacy

MOMETHASONE AND SYNTHESIS OF COLLAGEN

Skin Pharmacol. 1997; 10 (5-6): 261-4.

Study demonstrating that the use of mometasone together with that of other topical corticosteroids can optimize collagen synthesis, thus improving the clinical dermatological aspect.

MOMETHASONE IN THE TREATMENT OF PSORIASIS

Adv Ther. 2013 May; 30 (5): 503-16. doi: 10.1007 / s12325-013-0033-4. Epub 2013 May 25.

Work that evaluates the effectiveness of a new formulation based on Mometasone topically in the treatment of psoriasis, thus being able to provide another potential ally against this disease.

MOMETHASONE AND SEASONAL ALLERGIC RHINITIS

Allergy. 1999 Jan; 54 (1): 64-9.

Study that demonstrates the effectiveness of a Mometasone-based spray in the treatment of seasonal allergic rhinitis, ensuring a marked improvement in symptoms.

Method of use and dosage

ELOCON ®

Cream, Ointment and 0.1% Mometasone furoate skin solution.

The particular pharmacokinetic characteristics of Mometasone allow the application of the drug to be limited to only once a day, taking care to gently massage the affected area.

Application methods, timing and dosages must in any case necessarily be defined by the physician according to the patient's clinical conditions.

Warnings ELOCON ® Mometasone

Treatment with ELOCON ®, like other topical therapies with corticosteroid drugs, requires compliance with different health and hygiene standards, necessary to limit the potential side effects of the therapy itself.

For this reason, the doctor should inform patients about the appropriate behaviors to be taken and the potential side effects that the application of the drug could cause.

Avoid applying the medicine to eyes and mucous membranes, avoid using the drug for particularly long periods of time, avoid applying the medicine on particularly large skin areas, cleanse your hands after each application and contact your doctor immediately following the appearance of unwanted effects are just the main precautions that the patient should follow.

It is also recommended to keep the drug out of the reach of children.

PREGNANCY AND BREASTFEEDING

The use of ELOCON ® during pregnancy and in the subsequent period of breastfeeding is generally contraindicated.

However, always under the careful supervision of your doctor, its use could be justified in cases of inevitable necessity, taking care however to avoid the application on deeply damaged or particularly large areas.

Interactions

No known drug interactions are currently known.

Contraindications ELOCON ® Mometasone

The use of ELOCON ® is contraindicated in patients hypersensitive to the active ingredient or to one of its excipients, in patients suffering from viral, bacterial and fungal infections not adequately treated.

Undesirable effects - Side effects

The use of ELOCON ®, especially if continued over time or carried out in particularly large or damaged areas, could determine the appearance of local adverse reactions such as edema, burning, irritation, hypertrichosis, skin atrophy, skin dryness and dermatitis.

Fortunately, all the potential systemic side effects are rarer.